This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On November 20, 2024, the Office of Inspector General (OIG) released its updated Industry-Specific Compliance Program Guidance (ICPG) for nursing facilities, marking an important step in its broader compliance initiative. Both the 2000 CPG and 2008 Supplemental CPG will remain available as archived resources on the OIG website.
Department of Health and Human Services (HHS) issued new Industry Segment-Specific Compliance Program Guidance For Nursing Facilities (Nursing Facility ICPG) for nursing home members of the health care compliance community. Medical Directors in Nursing Homes 42 CFR 483.70(g) See 42 C.F.R.
in restitution for her role in healthcare fraud, wire fraud, and theft of government funds. Court documents show that between 2008 and 2016 the former owner defrauded the Texas Medicaid program by billing for items and services that had not been provided to the clients of the day care centers. US Attorney Ashley C.
Department of Health and Human Services (HHS), Office of the Inspector General (OIG), released 91 pages of "General Compliance Program Guidance" (GCPG) on its website. This is the first compliance program guidance the OIG has released since 2008. The GCPG provides general compliance guidance, [.]
On November 6, 2023, the US Department of Health and Human Services (HHS), Office of the Inspector General (OIG), released 91 pages of "General Compliance Program Guidance" (GCPG) on its website. This is the first compliance program guidance the OIG has released since 2008.
For example, the Administrative Requirements (Part 162) helped reduce insurance fraud and accelerated eligibility inquiries, authorization requests, and claims processing. Despite the benefits, the cost of implementing NPIs was forecast ( in 2008 ) to be between $1.5 billion and $11.5
Each ASC is responsible for ensuring that they are in compliance with the numerous statutes and regulations that are in place at both the state and federal levels. However, ASC billing practices must be followed to ensure proper reimbursement and regulatory compliance. ASCs must also meet Medicare’s Conditions for Coverage.
Department of Health and Human Services (“HHS”) issued new Industry Segment-Specific Compliance Program Guidance For Nursing Facilities (“Nursing Facility ICPG”) for nursing home members of the health care compliance community. On November 20, 2024, the Office of Inspector General (“OIG”) for the U.S.
You can view our H1, 2024 Report here.You can also receive a free copy of our HIPAA Compliance Checklist to understand your organization’s responsibilities under HIPAA. Check back regularly to get the latest healthcare data breach statistics and healthcare data breach trends. These figures are adjusted annually for inflation.
FY 2021 was also a record-shattering year for DOJ as it relates to health care fraud enforcement; over $5 billion (90% of the total) was obtained from cases pursued against individuals and entities in the health care and life sciences industries. With collections amounting to $5.6 billion received in FY 2020.
Now, almost three years later, governmental entities have focused their attention on telehealth services and the potential for fraud and abuse. Although it is likely the PHE will be extended again, providers should focus on compliance as it will eventually reach an end. in healthcare fraud for fraudulent telemedicine schemes.
It is unclear, however, whether this new regulatory framework will ultimately benefit requestors. at 1368 (emphasis added). However, OIG’s sentiment may presume too much. First, OIG appears to presuppose that any conduct under investigation by DOJ—by virtue of it being under investigation—is problematic.
As more and more potential and real fraud, waste, and abuse was uncovered in the FFS arena, it was also discovered that patient outcomes were less than stellar. It’s important for compliance and historical trend analysis. These different Acts initiated the testing of alternate forms of delivering care and payment methodologies.
For example, in October, 2008 , the OIG allowed a non-profit organization that provides outpatient treatment services for patients with psychoactive substance abuse dependence to offer incentives in the form of $5–$10 gift cards to motivate those patients to adhere to their treatment plans, which include urine drug screening and counseling sessions.
As more and more potential and real fraud, waste, and abuse was uncovered in the FFS arena, it was also discovered that patient outcomes were less than stellar. It's important for compliance and historical trend analysis. These different Acts initiated the testing of alternate forms of delivering care and payment methodologies.
Background on the Ryan Haight Act The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the “Ryan Haight Act”) made certain amendments to the CSA which established controls on the remote prescribing of controlled substances. Provider Education and Understanding About New Prescribing and Recordkeeping Requirements. 1301.28.
Lowest Total Recoveries Since 2008 Record-Shattering Number of New Cases Filed Health Care and Life Sciences Cases Continue to Dominate On February 7, 2023, the U.S. The total recoveries in fraud cases brought with respect to the health care and life sciences industries fell to the lowest level since 2009. Last year, $1.2
Last July, the Department of Health and Human Services’ Office of Inspector General (“OIG”) published a Special Fraud Alert detailing high-risk activities conducted by telehealth providers and has, to date, indicted 31 telehealth providers alleging various health care fraud and abuse schemes.
NATIONAL 3 big noncompete ban wins for physicians 5 systems join $50M poverty and cancer program AHA advises Congress how to advance MACRA payment models Amazon delays virtual care service’s unveiling after senators raised privacy concerns At AHA Hill briefing, hospital leaders say site-neutral payment cuts jeopardize access to care for patients and (..)
312 (2008). But what if the manufacturer allegedly failed to make its reports in compliance with the FDA’s restrictions on what types of adverse events were subject to ASR reporting? So, if a plaintiff contends that a defendant abused the ASR program, that is a Buckman -preempted fraud on the FDA claim. 2d 381 (Pa. 341 (2001).
Ohio is one of several states, with New Jersey being the most notable , with statutes precluding punitive damages in product liability cases based on FDA approval or compliance. 440 (2008), in the face of a contrary ruling from the Sixth Circuit in Garcia v. Warner-Lambert & Co. , 3d 85, 98 (2d Cir. Wyeth-Ayerst Labs. ,
440 (2008) Buckman was not cited at all in the Merck Sharp & Dohme Corp. 470 (1996), was decided – removing express preemption as a defense for manufacturers of §510(k) products So defendants moved on fraud on the FDA under an implied preemption theory and won. Plaintiffs Legal Committee , 531 U.S. Kent , 552 U.S. Albrecht , 139 S.
But state-law claims that rest on alleged fraud on the FDA are contrary to Buckman Co. 341 (2001), which concluded that fraud-on-the-FDA claims are impliedly preempted because they “inevitably conflict” with the FDA’s regulatory discretion under. 440 (2008)). 2022 WL 1261318, at *1 (quoting N.J. 21 U.S.C. § 3d 372 (5th Cir.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content